Abstract
Castrate resistant prostate cancer (CRPC) relies on the supply of potent androgens such as dihydrotestosterone (DHT) from intratumoral conversion from the precursor dehydroepiandrosterone (DHEA) for growth. Vitamin D has been proposed as a chemotherapeutic agent by way of vitamin D receptor(VDR) activation. The mechanistic enzymes of the intracrine pathway are influenced by VDR activation and thus can have a beneficial effect of the outcome of androgen synthesis, by reducing the active androgens produced. In this thesis, I aimed to explore the metabolic outcomes of vitamin D treatment upon a CRPC translation model, by assessing the androgen intracrine conversions using mass spectrometry-based techniques and genetic changes. Employing an in vitro based assay, effects of vitamin D treatment were assessed for metabolic changes within the CRPC steroid pathway, using a semiquantitative method. Further evaluation of key metabolic gene changes was also undertaken. Findings confirm that vitamin D treatment decreased the levels of potent androgens, with increased hydroxylation, linked to the upregulation of the gene CYP3A4.An in vivo prostate cancer xenograft was also evaluated for vitamin D treatment upon castration and DHEA introduction. Spatial distribution of endogenous androgens in prostatic cancerous tissue were assessed using mass spectrometry imaging. A method of chemical derivatisation for neutral endogenous androgens was developed using the ImagePrep device, enhancing ionisation efficiency for on-tissue analysis. Biological assays were also employed to determine any effects exhibited by the vitamin D treatment, such agene expression analysis and total androgen quantitation. Vitamin D was found to induce changes in slowing growth and lowering levels of potent androgens. To further explore vitamin D treatment assay capabilities, a novel chemical derivatisation method for mass spectrometry imaging was developed by screening numerous reagents for off and on-tissue analysis. Ion efficiency was enhanced for on-tissue endogenous vitamin D metabolites with successful imaging of derivatised 25-(OH)-D2 and 1,25-(OH)2-D3 in mouse kidneys.
Thesis is embargoed until 31st March 2022
| Date of Award | Mar 2020 |
|---|---|
| Original language | English |
| Supervisor | Diego Cobice (Supervisor) & Paul Thompson (Supervisor) |
Keywords
- mass spectrometry imaging
- on-tissue chemical derivatisation
- castrate resistance Prostate cancer
- metabolism
- androgen intracrinology
- vitamin D
Cite this
- Standard